Estimating infectiousness throughout SARS-CoV-2 infection course.


Journal

Science (New York, N.Y.)
ISSN: 1095-9203
Titre abrégé: Science
Pays: United States
ID NLM: 0404511

Informations de publication

Date de publication:
09 07 2021
Historique:
received: 15 03 2021
accepted: 21 05 2021
pubmed: 27 5 2021
medline: 23 7 2021
entrez: 26 5 2021
Statut: ppublish

Résumé

Two elementary parameters for quantifying viral infection and shedding are viral load and whether samples yield a replicating virus isolate in cell culture. We examined 25,381 cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in Germany, including 6110 from test centers attended by presymptomatic, asymptomatic, and mildly symptomatic (PAMS) subjects, 9519 who were hospitalized, and 1533 B.1.1.7 lineage infections. The viral load of the youngest subjects was lower than that of the older subjects by 0.5 (or fewer) log

Identifiants

pubmed: 34035154
pii: science.abi5273
doi: 10.1126/science.abi5273
pmc: PMC9267347
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NIAID NIH HHS
ID : HHSN272201400008C
Pays : United States

Informations de copyright

Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.

Références

JAMA Intern Med. 2020 Nov 01;180(11):1447-1452
pubmed: 32780793
Lancet Infect Dis. 2021 Jun;21(6):e163-e169
pubmed: 33301725
Clin Infect Dis. 2017 Mar 15;64(6):736-742
pubmed: 28011603
Z Gesundh Wiss. 2021 Feb 23;:1-8
pubmed: 33643779
J Infect Dis. 2021 May 28;223(10):1666-1670
pubmed: 33580259
MMWR Morb Mortal Wkly Rep. 2020 Aug 07;69(31):1023-1025
pubmed: 32759921
Lancet Infect Dis. 2020 May;20(5):565-574
pubmed: 32213337
J Infect Dis. 2010 May 15;201(10):1509-16
pubmed: 20377412
Nature. 2020 Aug;584(7821):425-429
pubmed: 32604404
PLoS One. 2016 May 06;11(5):e0154418
pubmed: 27153194
BMJ Open. 2020 Aug 16;10(8):e039652
pubmed: 32801208
Lancet Infect Dis. 2021 Jan;21(1):52-58
pubmed: 33058797
Gigascience. 2021 Feb 16;10(2):
pubmed: 33594436
JAMA Pediatr. 2021 Jan 1;175(1):73-80
pubmed: 32857112
N Engl J Med. 2020 Mar 26;382(13):1199-1207
pubmed: 31995857
Influenza Other Respir Viruses. 2018 May;12(3):326-330
pubmed: 29078028
N Engl J Med. 2010 Jun 10;362(23):2175-2184
pubmed: 20558368
Nat Commun. 2021 Jan 11;12(1):267
pubmed: 33431879
J Fam Pract. 2020 Nov;69(9):428-429
pubmed: 33176345
Mol Biol Evol. 2013 Apr;30(4):772-80
pubmed: 23329690
Epidemiology. 2015 Nov;26(6):862-72
pubmed: 26133025
Arch Dis Child. 2021 Jul;106(7):680-686
pubmed: 33172887
Wellcome Open Res. 2020 Apr 9;5:67
pubmed: 32685698
Science. 2020 Nov 6;370(6517):691-697
pubmed: 33154136
J Clin Virol. 2021 Feb;135:104713
pubmed: 33352470
Nat Med. 2020 Aug;26(8):1200-1204
pubmed: 32555424
Microorganisms. 2021 Apr 02;9(4):
pubmed: 33918332
MMWR Morb Mortal Wkly Rep. 2020 Oct 30;69(43):1600-1604
pubmed: 33119558
JAMA Pediatr. 2020 Sep 1;174(9):902-903
pubmed: 32745201
N Engl J Med. 2020 Sep 24;383(13):1283-1286
pubmed: 32857487
Lancet Infect Dis. 2020 Aug;20(8):911-919
pubmed: 32353347
Infection. 2020 Aug;48(4):619-626
pubmed: 32535877
Clin Infect Dis. 2020 Dec 17;71(10):2663-2666
pubmed: 32442256
Med (N Y). 2020 Dec 18;1(1):128-138.e3
pubmed: 32838352
Clin Infect Dis. 2021 Jul 15;73(2):e458-e465
pubmed: 32649743
Med (N Y). 2021 Feb 12;2(2):149-163.e4
pubmed: 33163984
Science. 2021 Jan 15;371(6526):
pubmed: 33234698
Nat Med. 2020 Nov;26(11):1714-1719
pubmed: 32943787
Lancet Infect Dis. 2020 Jun;20(6):656-657
pubmed: 32199493
Lancet Infect Dis. 2021 May;21(5):629-636
pubmed: 33545090
Nature. 2020 May;581(7809):465-469
pubmed: 32235945
Clin Infect Dis. 2021 Jul 1;73(1):148-150
pubmed: 32761228
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
BMJ. 2021 Mar 9;372:n579
pubmed: 33687922
Science. 2020 May 1;368(6490):489-493
pubmed: 32179701
Clin Infect Dis. 2021 Nov 2;73(9):e2952-e2959
pubmed: 33098412
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Science. 2021 Apr 9;372(6538):
pubmed: 33658326
Infection. 2021 Aug;49(4):703-714
pubmed: 33890243
JCI Insight. 2021 May 10;6(9):
pubmed: 33822777
PLoS One. 2012;7(12):e51653
pubmed: 23240050
J Clin Microbiol. 2009 Aug;47(8):2682-3
pubmed: 19494063
Euro Surveill. 2020 Jul;25(29):
pubmed: 32720636
Lancet Microbe. 2021 Jul;2(7):e311-e319
pubmed: 33846704
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
JAMA Intern Med. 2021 May 1;181(5):702-704
pubmed: 33180119
Euro Surveill. 2021 Jan;26(1):
pubmed: 33413740
N Engl J Med. 2020 May 28;382(22):2081-2090
pubmed: 32329971
J Infect Dis. 2012 Oct 1;206(7):1078-84
pubmed: 22837493
J Gen Virol. 2021 Mar;102(3):
pubmed: 33331810
Emerg Infect Dis. 2020 Sep;26(9):
pubmed: 32521222
Emerg Infect Dis. 2020 Nov;26(11):2701-2704
pubmed: 32749957
Nat Med. 2020 May;26(5):672-675
pubmed: 32296168
Eur J Clin Microbiol Infect Dis. 2020 Jun;39(6):1059-1061
pubmed: 32342252
Int J Epidemiol. 2000 Feb;29(1):158-67
pubmed: 10750618
Nat Med. 2020 Oct;26(10):1534-1535
pubmed: 32807935
Euro Surveill. 2021 Apr;26(15):
pubmed: 33860747
Genome Biol. 2019 Jan 8;20(1):8
pubmed: 30621750
BMJ. 2020 Apr 21;369:m1443
pubmed: 32317267
Microbes Infect. 2020 Nov - Dec;22(10):617-621
pubmed: 32911086
Clin Infect Dis. 2021 Nov 2;73(9):e2946-e2951
pubmed: 32840608
J Pediatr. 2020 Dec;227:45-52.e5
pubmed: 32827525
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794447

Auteurs

Terry C Jones (TC)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.
Centre for Pathogen Evolution, Department of Zoology, University of Cambridge, Cambridge CB2 3EJ, U.K.

Guido Biele (G)

Norwegian Institute of Public Health, 0473 Oslo, Norway.
University of Oslo, 0315 Oslo, Norway.

Barbara Mühlemann (B)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.

Talitha Veith (T)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.

Julia Schneider (J)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.

Jörn Beheim-Schwarzbach (J)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Tobias Bleicker (T)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Julia Tesch (J)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Marie Luisa Schmidt (ML)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.

Leif Erik Sander (LE)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.

Florian Kurth (F)

Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, 10117 Berlin, Germany.
Department of Tropical Medicine, Bernhard Nocht Institute for Tropical Medicine, and Department of Medicine I, University Medical Centre Hamburg-Eppendorf, 20359 Hamburg, Germany.

Peter Menzel (P)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Rolf Schwarzer (R)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Marta Zuchowski (M)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Jörg Hofmann (J)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Andi Krumbholz (A)

Institute for Infection Medicine, Christian-Albrechts-Universität zu Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany.
Labor Dr. Krause und Kollegen MVZ GmbH, 24106 Kiel, Germany.

Angela Stein (A)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Anke Edelmann (A)

Labor Berlin-Charité Vivantes GmbH, Sylter Straße 2, 13353 Berlin, Germany.

Victor Max Corman (VM)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.

Christian Drosten (C)

Institute of Virology, Charité--Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, 10117 Berlin, Germany. christian.drosten@charite.de.
German Centre for Infection Research (DZIF), partner site Charité, 10117 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH